retatrutide clinical trials update Retatrutide: What It Is & How This New Drug Works When will Retatrutide be available

Saxenda Saxenda, another weight loss drug manufactured by Novo Nordisk, is prescribed for patients to treat obesity and other chronic weight management needs

The benefits of GLP-1 medications in (overweight or obese) women with PCOS may include: While we need more research on GLP-1s and fertility in non-PCOS populations and women seeking fertility treatments, there is ample evidence for women with PCOS using GLP-1 medications for weight loss that the benefits extend to fertility as well

Berberine , a natural plant alkaloid , has been a supplement industry mainstay for over a decade, thanks to its powerful anti-diabetic effects [5,6] that can lead to healthy weight loss

Similarly, patients prescribed SGLT2 inhibitors both before and after the procedure increased substantially from 0.9% in 2018 to 4.3% in 2023, once again calling into question the extent to which SGLT2 inhibitors are a replacement versus a supplemental therapy